Bronchial Neoplasms Clinical Trials

Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

NCT06131840

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Mayo Clinic Scottsdale, Arizona, United States

City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States

IP Address: City of Hope Investigational Drug Services(IDS) Duarte, California, United States

View all 48 locations

View Trial Details

Recruiting

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

NCT05317858

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +15 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Miami Cancer Institute at Baptist Health Miami, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

View all 13 locations

View Trial Details

Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

NCT07070232

Conditions: Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +25 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

University of California San Francisco San Francisco, California, United States

Hartford Healthcare Hartford, Connecticut, United States

Yale University New Haven, Connecticut, United States

View all 67 locations

View Trial Details

Recruiting

A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07154290

Conditions: Advanced/Metastatic Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations: Cancer Treatment Centers of America, Phoenix Goodyear, Arizona, United States

The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States

Rush University Medical Center Chicago, Illinois, United States

University of Illinois Chicago Chicago, Illinois, United States

View Trial Details

Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06179160

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Stanford University Palo Alto, California, United States

UCLA Healthcare Hematology-Oncology Santa Monica, California, United States

Sarah Cannon Research Institue At Healthone Denver, Colorado, United States

View all 34 locations

View Trial Details

Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

NCT06758401

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations: Providence Medical Foundation Fullerton, California, United States

Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton, California, United States

St. Jude Heritage Medical Group - Fullerton Plaza Multi-Specialty Clinic (Pulmonary Function Test) Fullerton, California, United States

Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States

View all 372 locations

View Trial Details

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT06767514

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Clinical Study Site Chandler, Arizona, United States

Clinical Study Site Phoenix, Arizona, United States

Clinical Study Site Hot Springs, Arkansas, United States

Clinical Study Sites Jonesboro, Arkansas, United States

View all 270 locations

View Trial Details

Recruiting

Using Urine Samples to Identify Lung Cancer

NCT06033248

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

NCT07472517

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +9 more
Locations: Infirmary Cancer Care Mobile, Alabama, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Bioresearch Partner - Hialeah Hospital Hialeah, Florida, United States

Emory University Atlanta, Georgia, United States

View all 242 locations

View Trial Details

Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

NCT06996782

Conditions: Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations: Research Site Phoenix, Arizona, United States

Research Site Santa Rosa, California, United States

Research Site Jacksonville, Florida, United States

Research Site Baltimore, Maryland, United States

View all 103 locations

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions